COMP <GO>
AMPY vs CVX // ALTMAN Z-SCORE & DEBT/EQUITY
Amplify Energy Corp. (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: AMPY 6
— CVX 5
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: CVX
LAST: $4.33 (-1.37%) • MKT CAP: $179.5M
balance-sheet
1.79
LAST: $231.46 (+0.99%) • MKT CAP: $457.31B
balance-sheet
3.71
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMPY VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMPY | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 93.20% | 41.30% | +51.90 | AMPY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.30% | 5.80% | +9.50 | AMPY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 21.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 5.61% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 29.20% | 8.10% | +21.10 | AMPY | /operating-margins <GO> |
| Net Profit Margin | 16.70% | 6.70% | +10.00 | AMPY | /net-margins <GO> |
| Revenue Growth (YoY) | -10.60% | -4.60% | -6.00 | CVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.79% | -2.79 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 1.79 | 3.71 | -1.92 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | AMPY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.4 | 64.7 | -19.30 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.07 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.8x | 34.6x | -30.80 | AMPY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $179.5M | $457.31B | -$457.13B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMPY REV | CVX REV | AMPY GROSS % | CVX GROSS % | AMPY FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $263.4M | $184.43B | 93.2% | 41.3% | $49.2M | $25.64B |
| FY 2024 | $294.7M | $193.41B | 93.7% | 38.4% | $51.3M | $22.79B |
| FY 2023 | $307.6M | $196.91B | — | — | $141.6M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMPY // BETA —
CVX // BETA 1.07